If you are researching **AOD-9604** as a **fat loss peptide**, you have likely encountered conflicting information about its effectiveness, legal status, and how it compares to FDA-approved **weight loss peptides** like semaglutide
Until then, treat BPC-157 as high-risk and stay updated
This includes reviewing your weight loss trajectory since surgery, assessing adherence to dietary and lifestyle recommendations, and evaluating for any anatomical or functional complications from the surgery
Participants can receive standard of care therapies (defined as treatment with an approved AD medication, including an acetylcholinesterase inhibitor, memantine, or an anti-amyloid monoclonal antibody, or combinations of these agents) during the trial
Are GLP-1s prescribed by Walgreens Weight Management covered by insurance